Zarbee's acquisition lifts J&J's OTC business

19 July 2019 - Deborah Wilkes

Premium

Johnson & Johnson's (J&J's) OTC sales in the US increased by 6.6% to USD484 million in the second quarter of 2019, following the acquisition of natural health specialist Zarbee's.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: